SCHEMBL26689591

SCHEMBL26689591

COC(=O)c1cc(OC2CNC2)ccc1N

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 4/20 0.49
HSD17B10 Q99714 3/20 0.49
GAA P10253 3/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 2/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CFTR P13569 1/20 0.44
GLA P06280 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ATM Q13315 1/20 0.41
ABL1 P00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20972285 0.87 KDM4E (0.53) ALDH1A1KDM4EHSD17B10GAAMAPT
SCHEMBL7400353 0.82 CA12 (0.55) ALDH1A1GAAHPGDTSHRSLC6A2
SCHEMBL13162540 0.81 ALDH1A1 (0.47) ALDH1A1KDM4EHSD17B10GAAMAPT
SCHEMBL267307 0.77 KDM4E (0.62) ALDH1A1KDM4EHSD17B10GAAMAPT
Hydrochloric Acid SCHEMBL5100210 0.76 ALDH1A1 (0.60) ALDH1A1KDM4EHSD17B10GAAMAPT
SCHEMBL22749358 0.75 ALDH1A1 (0.55) ALDH1A1KDM4EHSD17B10GAAMAPT
SCHEMBL26689697 0.75 HDAC1 (0.43) ALDH1A1KDM4EHSD17B10GAAMAPT
SCHEMBL13362085 0.75 ALDH1A1 (0.56) ALDH1A1HSD17B10TSHRSLC6A2SLC6A4
SCHEMBL1026723 0.75 BRAF (0.56) ALDH1A1KDM4EHSD17B10GAAMAPT
SCHEMBL6168887 0.73 GAA (0.66) ALDH1A1KDM4EHSD17B10GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326713-A1 INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2025-10-23 US disclosed
EP-4525852-A1 INHIBITORS OF MSBA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF Merck Sharp & Dohme LLC (US) 2025-03-26 EP disclosed
WO-2023224893-A1 INHIBITORS OF MSBA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2023-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326713-A1 INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MSRB3, ARSA, ABCG2 ALDH1A1 3837/4885KDM4E 848/4885HSD17B10 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.